Kole Krieger
Kole Krieger is Senior Vice President at Lumen Bioscience and self-employed President at Krieger Biotech Consulting. He was Vice President, Business Development at Absci and Co-Founder at Aerospectiv. He is also Strategic Advisor at flok Health.
Seattle Biotech Lumen Bioscience Raises $30M Series C Extension, Adds Microsoft Vet Jeff Raikes to Board
Seattle biotech startup Lumen Bioscience raised a $30 million Series C extension led by WestRiver Group, bringing total funding to $186.8 million to advance its oral biologic drugs. The company also added Microsoft veteran Jeff Raikes to its board and announced several leadership updates.
Lumen Bioscience adds Jeff Raikes to board, promotes executives and secures $30M Series C extension led by WestRiver Group
Lumen Bioscience announced board and leadership changes—including Jeff Raikes joining as an independent director, promotions of Nhi Khuong and Kole Krieger, and appointment of David Saunders—and elected Erik Anderson as Vice Chairman. The company also closed an oversubscribed $30 million Series C extension led by WestRiver Group with participation from the Gates Foundation and several new investors to support its orally delivered biologics clinical pipeline.
Organizations
See all 5-
Lumen Bioscience SVP, Business Development 2025–present, Vice President Of Business Development 2022–2025 · current
-
Krieger Biotech Consulting President 2022–present · current
-
flok Health Strategic Advisor 2025–present · current
Education
-
Linfield University Bachelor of Science (BS), Finance · 2008–2012
-
Graduate Sherwood High School Honors Diploma · 2005–2008